findmyKOL

Andrew Avarbock, MD, PhD

Basic profile

Cornell University

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Andrew Avarbock is a Dermatology physician affiliated with Cornell University. OpenAlex indexes 12 publications with 595 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
12publications

Distinct works indexed by OpenAlex.

595citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

156 William St
7th Floor
New York, NY 100382609

Telephone

646-962-3376

Registry record last updated 15 Oct 2013.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    27.9%
    Corticosteroid18.6%
    Triamcinolone Acetonide55%Triamcinolone acetonide45%
    Part D + Part B51 patients
    alpha-Hydroxy Acid4.9%
    Ammonium Lactate100%
    Part D16 patients

    + 1 more class in this area

  • Anti-infectives

    23.3%
    Azole Antifungal10.6%
    Ketoconazole100%
    Part D28 patients
    Tetracycline-class Drug5.5%
    Doxycycline Hyclate100%
    Part D17 patients

    + 2 more classes in this area

  • Cancer & immunology

    13.7%
    Nucleoside Metabolic Inhibitor8.8%
    Fluorouracil100%
    Part D + Part B19 patients
    Calcineurin inhibitor2.9%
    Tacrolimus100%
    Part D12 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”